FDA authorizes first revamp of COVID vaccines to target omicron

Argentina Noticias Noticias

FDA authorizes first revamp of COVID vaccines to target omicron
Argentina Últimas Noticias,Argentina Titulares
  • 📰 KTOOpubmedia
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 53%

The Food and Drug Administation authorized reformulated versions of the Moderna and Pfizer-BioNTech vaccines that aim to protect against the omicron variant.

Vials of the newly reformulated COVID-19 vaccine booster are being readied by Pfizer for distribution now that the Food and Drug Administration has authorized the shots for people 12 and older.

“The FDA has been planning for the possibility that the composition of the COVID-19 vaccines would need to be modified to address circulating variants. … We have worked closely with the vaccine manufacturers to ensure the development of these updated boosters was done safely and efficiently,” said Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research,. “The FDA has extensive experience with strain changes for annual influenza vaccines.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

KTOOpubmedia /  🏆 439. in US

Argentina Últimas Noticias, Argentina Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

FDA Clears Updated COVID Boosters Targeting Newest VariantsFDA Clears Updated COVID Boosters Targeting Newest VariantsFederal regulators on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most common omicron strain.
Leer más »

Pediatric cases rise as Biden administration prepares for rollout of new COVID vaccine boostersPediatric cases rise as Biden administration prepares for rollout of new COVID vaccine boostersExperts predict the FDA could authorize a new COVID-19 booster shot that includes a new formula aimed at targeting the latest omicron variants as early as this week.
Leer más »

FDA expected to authorize new omicron-specific COVID boosters this weekFDA expected to authorize new omicron-specific COVID boosters this weekThe Food and Drug Administration is planning to authorize a new generation of COVID-19 boosters this week that for the first time will target the omicron variant.
Leer más »

FDA expected to authorize new omicron-specific COVID boosters this weekFDA expected to authorize new omicron-specific COVID boosters this weekThe Food and Drug Administration is planning to authorize a new generation of COVID-19 boosters this week that for the first time will target the omicron variant.
Leer más »

FDA expected to authorize new omicron-specific COVID boosters this weekFDA expected to authorize new omicron-specific COVID boosters this weekThe Food and Drug Administration is planning to authorize a new generation of COVID-19 boosters this week that for the first time will target the omicron variant.
Leer más »



Render Time: 2025-03-09 19:51:29